0001209191-24-004827.txt : 20240313
0001209191-24-004827.hdr.sgml : 20240313
20240313203300
ACCESSION NUMBER: 0001209191-24-004827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240312
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Darrel P.
CENTRAL INDEX KEY: 0001989794
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 24747613
MAIL ADDRESS:
STREET 1: C/O VIRACTA THERAPEUTICS, INC.
STREET 2: 2533 S. COAST HWY 101, SUITE 210
CITY: CARDIFF
STATE: CA
ZIP: 92007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viracta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2533 S COAST HWY 101
STREET 2: SUITE 210
CITY: CARDIFF
STATE: CA
ZIP: 92007
BUSINESS PHONE: 858-400-8470
MAIL ADDRESS:
STREET 1: 2533 S COAST HWY 101
STREET 2: SUITE 210
CITY: CARDIFF
STATE: CA
ZIP: 92007
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
FORMER COMPANY:
FORMER CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980501
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-03-12
0
0001061027
Viracta Therapeutics, Inc.
VIRX
0001989794
Cohen Darrel P.
C/O VIRACTA THERAPEUTICS, INC.
2533 S. COAST HWY 101, SUITE 210
CARDIFF
CA
92007
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
0.985
2024-03-12
4
A
0
120000
0.00
A
2034-03-12
Common Stock
120000
120000
D
1/48th of the total shares subject to the Option will vest each month on the same day of the month as the Vesting Commencement Date (as defined below), and if there is no corresponding day, the last day of the month, subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is January 1, 2024.
/s/ Daniel Chevallard, as Attorny-in-Fact
2024-03-13